title: Longer overall survival in a patient with advanced non-small cell lung cancer treated with Chinese medicine and chemotherapy.
authors.affiliation: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Integration of Traditional Chinese and Western Medicine, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing 100142, China.
authors.forename: Yan-Zhi
authors.initials: YZ
authors.lastname: Chen
authors.forename: Zhan-Dong
authors.initials: ZD
authors.lastname: Li
authors.forename: Ning
authors.initials: N
authors.lastname: Zhou
authors.forename: Hong
authors.initials: H
authors.lastname: Sun
authors.forename: Ping-Ping
authors.initials: PP
authors.lastname: Li
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology*; D000077143:Docetaxel; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D009367:Neoplasm Staging; D016019:Survival Analysis; D043823:Taxoids / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed
chemical_list: D000970:Antineoplastic Agents; D004365:Drugs, Chinese Herbal; D043823:Taxoids; D000077143:Docetaxel